Nebulizers Market Share

Global Nebulizers Market Overview

Nebulizers Market is expected to hold a value of USD 1.45 Billion by 2032 and is expected to register a growth of 6.9% from 2023 to 2032. Nebulizers are a device that has the capability of changing a medication from a liquid to a mist so that it can be inhaled into the lungs. High demand for respiratory devices, including nebulizers, due to the outbreak of COVID-19 globally, growing need for rescue medication, increasing prevalence of respiratory diseases, and rising demand for home healthcare devices are the key factors that are expected to drive the market growth. 

Moreover, the growing geriatric population, increasing consumption of alcohol, tobacco, cigarettes, and other such products may lead to respiratory diseases, and the rising number of initiatives taken by the government as well as the private organizations are also expected to boost the nebulizers market growth. The outbreak of COVID-19, leading to increased demand for respiratory devices, including nebulizers.

Nebulizers Market Trends

Nebulizers Market Drivers

• High demand for respiratory devices, including nebulizers, due to outbreak of COVID-19 globally

• Growing need for rescue medication. Uncertain asthma attacks are the major reasons to increase the demand for nebulizers. According to the American College of Allergy, Asthma, and Immunology, every year more than 3,500 people die because of asthma. Rescue medication, such as the nebulizers, helps in better serving the patients suffering from asthma every year, hence driving the market growth.

• Increasing prevalence of chronic respiratory diseases. According to a report published by the World Health Organization (WHO), in 2017, approximately 65 million people suffered from chronic obstructive pulmonary disease (COPD) and 3 million die because of it every year, globally.

• Rising demand for home healthcare devices

• Growing geriatric population

• Increasing consumption of alcohol, tobacco, cigarettes, and other such products that may lead to respiratory diseases

Restraints

• Loss of drug during the nebulization process


• Availability of substitutes of nebulizers


• Side effects of nebulizer solutions

Nebulizers Market Segment Insights

Nebulizers Type Insights

Nebulizers Usage Insights

Nebulizers Portability Insights

Nebulizers End-User Insights

Hospitals and Clinics: This segment is expected to grow significantly, owing to the rising patient population.

Homecare: This segment is expected to demonstrate the fastest growth owing to its cost-effectiveness over other options.

Others: This includes research and academic institutes and specialty centers, among others.

Nebulizers Regional Insights

The largest regional market. The rising prevalence of respiratory disorders and favorable reimbursement schemes in the region is expected to drive the nebulizers market growth. According to data published by the Centers for Disease Control and Prevention in May 2017, about 9 million people in the US were diagnosed with chronic bronchitis. Moreover, increasing awareness regarding nebulizers amongst the people is also expected to contribute to market growth.

The market in Europe held the second-largest position in 2018 owing to the growing geriatric population. According to a report published by the European Union, approximately 29.6% of people in Europe are above the age of 65. Moreover, rising demand for technologically advanced devices in the region is also expected to boost the market growth.

The fastest-growing regional market. The growth of the market in this region is owing to the rising number of respiratory disorder cases. According to a report published by the World Health Organization (WHO), in 2018, approximately 1.31 billion people in India suffered from asthma. The increasing focus of market players on the Asia-Pacific market is also expected to boost nebulizers market growth.

The market is expected to show steady growth due to the rising burden of respiratory diseases. According to a report published by the National Center for Biotechnology Information (NCBI) in May 2018, the prevalence of asthma in the Middle Eastern countries ranges from 4.4% to 7.6%. Furthermore, slowly developing healthcare infrastructure is also expected to boost the market growth.

Nebulizers Market Key Players

• OMRON Healthcare (Japan)


• Koninklijke Philips N.V. (Netherlands)


• PARI (US)


• Vectura Group plc (UK)


• Rossmax International Ltd (Taiwan)


• Briggs Healthcare (US)


• GF Health Products, Inc. (US)


• Beurer GmBH (Germany)


• Agilent Technologies, Inc. (US)


• Drive DeVilbiss Healthcare (US)


• Invacare Corporation (US)


• Braun Melsungen AG (Germany)